Skip to content

Author

Aikseng Ooi

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Development of Isoform-Selective GRP78 Inhibitors from a Direct-to-Biology Strategy

The development of isoform-selective HSP70 inhibitors remains challenging due to the high conservation of this chaperone family. Continuing our efforts to target the peptide-binding pocket within the substrate-binding domain (SBD) of GRP78 (BiP/HSPA5), we identified compound 12 using a Direct-to-Biology (D2B) strateg...

Xiao-Yi Zhu, Qiu Li, Ke Wang et al. · 0 citations
Open access Aug 2026

NRF2-mediated ferroptosis suppression defines a cancer-specific vulnerability in tumors

This discovery fundamentally redefines the pathological role of NRF2 and positions NRF2 inhibition as a standalone, tumor-selective therapeutic strategy to eliminate Kras-driven malignancies by unleashing ferroptosis.

Dichun Huang, Mae Zhang, Ben N Stansfield et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.